Researchers from King’s College London have unveiled a groundbreaking blood test capable of detecting Alzheimer’s disease up to 10 years before symptoms emerge.

This innovation could transform how the disease is diagnosed and treated, offering patients a better chance at early intervention. The test identifies protein markers linked to brain degeneration, reducing the need for costly brain scans.

Health experts worldwide have praised the discovery, calling it one of the most promising medical advancements of the decade. The UK’s leadership in neuroscience continues to make a global impact in the fight against degenerative diseases.